BIOCEPT, INC. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 32 rows in 2014. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2014-12-18: Reporting owner Singh Veena; Form 4; Security Stock option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2014-06-12: Reporting owner Nall Michael W.; Form 4; Security Stock Options (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2014-05-16: Reporting owner Kachioff William G; Form 4; Security Stock Options (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2014-05-16: Reporting owner Bischoff Farideh Z.; Form 4; Security Stock Options (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2014-12-18 | Singh Veena Officer (Sr VP & Sr Med Director) | 4 | Stock option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +40,000 40,000 owned after | $2.79 exercise price | 2014-12-22 | |
| 2014-06-12 | Nall Michael W. Director, Officer (CEO AND PRESIDENT) | 4 | Stock Options (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +75,000 75,000 owned after | $5.35 exercise price | 2014-06-16 | |
| 2014-05-16 | Kachioff William G Officer (SVP, CFO AND SECRETARY) | 4 | Stock Options (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,000 50,000 owned after | $4.38 exercise price | 2014-05-20 | |
| 2014-05-16 | Bischoff Farideh Z. Officer (VICE PRESIDENT) | 4 | Stock Options (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +35,000 35,000 owned after | $4.38 exercise price | 2014-05-20 | |
| 2014-05-16 | ARNOLD LYLE J Officer (SVP, Chief Scientific Officer) | 4 | Stock Options (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +35,000 35,000 owned after | $4.38 exercise price | 2014-05-20 | |
| 2014-03-24 | Trivedi Raaj Officer (VP, COMMERCIAL OPERATIONS) | 4 | Stock Options (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +43,000 43,000 owned after | $7.50 exercise price | 2014-06-06 | |
| 2014-02-21 | Kachioff William G Officer (SVP, CFO AND SECRETARY) | 4 | Stock Options (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,190 1,190 owned after | $9.11 exercise price | 2014-02-24 | |
| 2014-02-21 | HALE DAVID F Director, Officer (CHAIRMAN) | 4 | Stock Options (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +53,108 53,108 owned after | $9.11 exercise price | 2014-02-24 | |
| 2014-02-13 | Wilson Margaret Faye Director | 4 | Stock Options (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +51,000 51,000 owned after | $8.88 exercise price | 2014-02-18 | |
| 2014-02-13 | ROYSTON IVOR Director | 4 | Stock Options (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +26,500 26,500 owned after | $8.88 exercise price | 2014-02-18 | |
| 2014-02-13 | Neff Edward A. Director | 4 | Stock Options (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +23,000 23,000 owned after | $8.88 exercise price | 2014-02-18 | |
| 2014-02-13 | HUEBNER BRUCE A Director | 4 | Stock Options (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +22,000 22,000 owned after | $8.88 exercise price | 2014-02-18 | |
| 2014-02-13 | HALE DAVID F Director, Officer (CHAIRMAN) | 4 | Stock Options (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +70,000 70,000 owned after | $8.88 exercise price | 2014-02-18 | |
| 2014-02-13 | Gerhardt Bruce Director | 4 | Stock Options (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +23,000 23,000 owned after | $8.88 exercise price | 2014-02-18 | |
| 2014-02-13 | Chandler Marsha Alpert Director | 4 | Stock Options (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +23,000 23,000 owned after | $8.88 exercise price | 2014-02-18 | |
| 2014-02-04 holding as of filing | Kachioff William G Officer (SVP, CFO AND SECRETARY) | 3 | Stock Options (right to buy) Derivative · Direct | Holding | $4.62 exercise price | 2014-02-04 | ||
| 2014-02-04 holding as of filing | Kachioff William G Officer (SVP, CFO AND SECRETARY) | 3 | Stock Options (right to buy) Derivative · Direct | Holding | $5.18 exercise price | 2014-02-04 | ||
| 2014-02-04 holding as of filing | Kachioff William G Officer (SVP, CFO AND SECRETARY) | 3 | Contingent right to receive Stock Options (right to buy) Derivative · Direct | Holding | no price filed | 2014-02-04 | ||
| 2014-02-04 holding as of filing | Bischoff Farideh Z. Officer (VICE PRESIDENT) | 3 | Stock Options (right to buy) Derivative · Direct | Holding | $5.04 exercise price | 2014-02-04 | ||
| 2014-02-04 holding as of filing | Bischoff Farideh Z. Officer (VICE PRESIDENT) | 3 | Stock Options (right to buy) Derivative · Direct | Holding | $5.04 exercise price | 2014-02-04 | ||
| 2014-02-04 holding as of filing | Bischoff Farideh Z. Officer (VICE PRESIDENT) | 3 | Stock Options (right to buy) Derivative · Direct | Holding | $5.18 exercise price | 2014-02-04 | ||
| 2014-02-04 holding as of filing | ARNOLD LYLE J Officer (SVP, Chief Scientific Officer) | 3 | Stock Options (right to buy) Derivative · Direct | Holding | $4.62 exercise price | 2014-02-04 | ||
| 2014-02-04 holding as of filing | ARNOLD LYLE J Officer (SVP, Chief Scientific Officer) | 3 | Stock Options (right to buy) Derivative · Direct | Holding | $5.18 exercise price | 2014-02-04 | ||
| 2014-02-04 holding as of filing | ARNOLD LYLE J Officer (SVP, Chief Scientific Officer) | 3 | Contingent right to receive Stock Options (right to buy) Derivative · Direct | Holding | no price filed | 2014-02-04 | ||
| 2014-02-04 holding as of filing | Wilson Margaret Faye Director | 3 | Stock Options (right to buy) Derivative · Direct | Holding | $5.04 exercise price | 2014-02-04 | ||
| 2014-02-04 holding as of filing | ROYSTON IVOR Director | 3 | Stock Options (right to buy) Derivative · Direct | Holding | $4.62 exercise price | 2014-02-04 | ||
| 2014-02-04 holding as of filing | Nall Michael W. Director, Officer (CEO AND PRESIDENT) | 3 | Stock Options (right to buy) Derivative · Direct | Holding | $5.18 exercise price | 2014-02-04 | ||
| 2014-02-04 holding as of filing | HUEBNER BRUCE A Director | 3 | Stock Options (right to buy) Derivative · Direct | Holding | $5.18 exercise price | 2014-02-04 | ||
| 2014-02-04 holding as of filing | Gerhardt Bruce Director | 3 | Stock Options (right to buy) Derivative · Direct | Holding | $4.62 exercise price | 2014-02-04 | ||
| 2014-02-04 holding as of filing | Chandler Marsha Alpert Director | 3 | Stock Options (right to buy) Derivative · Direct | Holding | $5.18 exercise price | 2014-02-04 | ||
| 2014-02-04 holding as of filing | HALE DAVID F Director, Officer (EXECUTIVE CHAIRMAN) | 3 | Stock Options (right to buy) Derivative · Direct · (m) | Holding | $5.18 exercise price | 2014-02-04 | ||
| 2014-02-04 holding as of filing | HALE DAVID F Director, Officer (EXECUTIVE CHAIRMAN) | 3 | Contingent right to receive Stock Options (right to buy) Derivative · Direct · (m) | Holding | no price filed | 2014-02-04 |